Boron neutron capture therapy for urological cancers

Area of Science:

• Oncology
• Nuclear Medicine
• Radiation Therapy

Background:

• Boron neutron capture therapy (BNCT) is a binary treatment modality utilizing the nuclear reaction between boron-10 and neutrons.
• BNCT generates high linear energy transfer (LET) alpha particles and lithium nuclei, selectively targeting and destroying tumor cell DNA.
• This therapy aims to enhance the therapeutic ratio in cancer treatment.

Purpose of the Study:

• To provide an updated summary of the clinical literature on patients treated with BNCT.
• To explore the future prospects of BNCT for urological cancers.

Main Methods:

• Review of current clinical literature on BNCT applications.
• Focus on studies involving various malignancies and potential urological cancer treatments.

Main Results:

• BNCT has been clinically studied in glioblastoma, head and neck cancer, melanoma, hepatocellular carcinoma, lung cancer, and extramammary Paget's disease.
• BNCT has not been clinically applied to urological cancers, with the exception of genital extramammary Paget's disease.

Conclusions:

• BNCT shows promise for improving cancer treatment outcomes.
• Further research and clinical trials are needed to establish BNCT efficacy for urological malignancies.